Dr. Sinclair said experiments at Sirtris had essentially wrapped up this point.

Sirtris will remain an autonomous unit within Glaxo, with Dr. Westphal in charge.

But a company he helped start, Sirtris Pharmaceuticals, is testing the safety of a resveratrol treatment in people with diabetes.